We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Tramadol Versus Lidocaine Infiltration for Tonsillectomy

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01552096
First Posted: March 13, 2012
Last Update Posted: March 18, 2014
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Dammam University
  Purpose
The investigators postulate that the use of pre-incisional peritonsillar infiltration of tramadol or lidocaine reduces both the inflammatory response and postoperative analgesic consumption, without harmful effects. Therefore, the present study is designed to evaluate the effects of infiltration of tramadol or lidocaine on the postoperative acute-phase serum protein, C-reactive protein, and analgesic consumption after tonsillectomy.

Condition Intervention Phase
Peri-tonsillar Analgesic Infiltration Tonsillectomy Postoperative Pain Inflammatory Response Drug: peritonsillar infiltration Phase 2

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Triple (Participant, Care Provider, Investigator)
Primary Purpose: Treatment
Official Title: A Comparative Study of the Effects of Pre-incisional Infiltration of Tramadol or Lidocaine on the Inflammatory Response After Tonsillectomy.

Resource links provided by NLM:


Further study details as provided by Dammam University:

Primary Outcome Measures:
  • inflammatory and stress response [ Time Frame: 24 hours ]
    CRP Acute phase protein


Secondary Outcome Measures:
  • Hemodynamic changes [ Time Frame: 24 hours ]
    MBP HR

  • pain score [ Time Frame: 24 hours ]
    VAS The time to first request for analgesia and the number of subjects receiving meperidine during the first 12 hours will be recorded.

  • Side-effects [ Time Frame: 24 hours ]
    postoperative stridor, laryngospasm, cyanosis, bleeding, seizures, sedation (four-point verbal rating scores (VRS): awake, drowsy, rousable or deep sleep); nausea and vomiting (0: no nausea; 1: nausea no vomiting; 2: nausea and vomiting), respiratory depression (ventilatory frequency 10), and desaturation (92%), at 0, 1, 2, 4, 6, 8, and 12 h after surgery.


Enrollment: 90
Study Start Date: December 2011
Study Completion Date: November 2013
Primary Completion Date: October 2013 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Placebo Comparator: Placebo
The placebo group (n=30) will receive a submucosal infiltration with 3 mL of normal saline (1.5 ml around each tonsil), 3 minutes before surgical incision.
Drug: peritonsillar infiltration
1.5 ml around each tonsil, 3 minutes before surgical incision as per group description
Other Name: as in description
Active Comparator: lidocaine
will receive a total of 2 mg.kg-1 of 2% lidocaine HCl (Xylocaine, Astra-Zeneca,) in 3 mL of normal saline (1.5 ml around each tonsil), 5 minutes before surgical incision.
Drug: peritonsillar infiltration
1.5 ml around each tonsil, 3 minutes before surgical incision as per group description
Other Name: as in description
Experimental: Tramadol
(n=30) will receive a submucosal infiltration with 2 mg kg-1 tramadol in 3 mL of normal saline (1.5 ml around each tonsil), 3 minutes before surgical incision.
Drug: peritonsillar infiltration
1.5 ml around each tonsil, 3 minutes before surgical incision as per group description
Other Name: as in description

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   2 Years to 6 Years   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • ASA I & II preschool children aged 2-6 years, undergoing elective tonsillectomy with or without adenoidectomy, under general anaesthesia. Indications for tonsillectomy will be chronic recurrent tonsillitis or tonsillar hypertrophy

Exclusion Criteria:

  • Patients with a history of allergy to tramadol or amide local anaesthetics, epilepsy, or taking cardiovascular, antihypertensive, steroids, or anti-inflammatory medications, those with cardiac, liver, or kidney diseases, or any underlying systemic diseases or acute infectious processes will be excluded from the study. All operations will be performed, using an electro-dissection technique, by the same surgeon.
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01552096


Locations
Saudi Arabia
Dammam University KFHU
Al-Khobar, EP, Saudi Arabia, 31952
UD-KFHU
Al-Khobar, EP, Saudi Arabia, 31952
Sponsors and Collaborators
Dammam University
Investigators
Principal Investigator: laila Telmesani, MD UD
Study Chair: Hany A. Mowafi, MD Associate Professor
Study Chair: Alaa M. Khidr, MD Assistant Consultant
Study Chair: Abdulhadi Al'Saflan, MD Assistant Consultant
  More Information

Responsible Party: Dammam University
ClinicalTrials.gov Identifier: NCT01552096     History of Changes
Other Study ID Numbers: #2012082
First Submitted: March 5, 2012
First Posted: March 13, 2012
Last Update Posted: March 18, 2014
Last Verified: March 2014

Keywords provided by Dammam University:
Anaesthesia
tonsillectomy
inflammatory response
stress response
tramadol
lidocaine

Additional relevant MeSH terms:
Pain, Postoperative
Pain
Neurologic Manifestations
Nervous System Diseases
Postoperative Complications
Pathologic Processes
Signs and Symptoms
Lidocaine
Tramadol
Anesthetics, Local
Anesthetics
Central Nervous System Depressants
Physiological Effects of Drugs
Sensory System Agents
Peripheral Nervous System Agents
Anti-Arrhythmia Agents
Voltage-Gated Sodium Channel Blockers
Sodium Channel Blockers
Membrane Transport Modulators
Molecular Mechanisms of Pharmacological Action
Analgesics, Opioid
Narcotics
Analgesics


To Top